Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 324 clinical trials
None
Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

There is no muture method to treat EGFR 20 insertion mutation non-small-cell lung cancer (NSCLC). the he purpose of this study is to study osimertinib combined with bevacizumab in the management

epidermal growth factor receptor
Accepts healthy volunteers
epidermal growth factor
growth factor
bevacizumab
  • 0 views
  • 14 Nov, 2021
  • 1 location
None
A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) Anlotinib Plus CapeOx Bevacizumab Plus CapeOx

A clinical study to compare the efficacy and safety of AK105 plus anlotinib and Capecitabine/Oxaliplatin (CapeOx) , anlotinib plus CapeOx, bevacizumab plus CapeOx. A total of 120 cases will be

  • 0 views
  • 28 Oct, 2021
  • 13 locations
None
A Phase II Study Of Gliadel Concomitant Temozolomide And Radiation Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma

dose dense temozolomide and bevacizumab in subjects undergoing initial surgery for newly-diagnosed high grade glioma.

temozolomide
cerebral tumor
gliadel
MRI
bevacizumab
  • 9 views
  • 07 Nov, 2020
  • 1 location
None
Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone in Patients With Neovascular Age Related Macular Degeneration (AMD)

This is s randomized, multi-center, double blind, 3 arm, phase I/II pilot study to evaluate the safety and efficacy of treatment with ORA102 combined with Avastin (Bevacizumab) versus

corrected visual acuity
avastin
bevacizumab
age-related macular degeneration
  • 30 views
  • 07 Nov, 2020
  • 1 location
None
Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

bevacizumab in the management of patients with brain metastasis harboring EGFR mutation.

epidermal growth factor receptor
growth factor
epidermal growth factor
bevacizumab
lung carcinoma
  • 0 views
  • 11 Nov, 2021
  • 1 location
None
A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer

The aim of BEVAMAINT is to improve benefic effect of maintenance therapy after a first line of induction chemotherapy for patients with colorectal cancer

  • 0 views
  • 07 Nov, 2021
  • 1 location
None
  • 0 views
  • 21 Jul, 2021
  • 1 location
None
Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels

-fluorouracile, Oxaliplatin, Irinotecan and Bevacizumab, are beneficial for patients having a bad prognostic, defined by the BRAFV600E mutation, concerning 5-8% of first line mCRC. For the 30% of

colorectal adenocarcinoma
metastatic colorectal adenocarcinoma
adenocarcinoma
capecitabine
folfoxiri
  • 6 views
  • 03 Aug, 2021
  • 13 locations
None
The Sahlgrenska Anti-VEGF Study

The study investigates whether patients treated for neovascular (wet) age-related macular degeneration (AMD), with intravitreal injection with bevacizumab (Avastin) after two years need more

  • 0 views
  • 04 Feb, 2021
  • 1 location
None
VASCular Impact of Angiogenic Treatment in Patients With Advanced Colorectal Cancer

antiangiogens used in this indication is that of monoclonal antibodies, the leader of which is bevacizumab (Avastin, Roche, Bale, Switzerland). Bevacizumab works by inhibiting endothelial vascular growth factor

  • 0 views
  • 03 Apr, 2021
  • 1 location